In Phase Ia clinical study,GZR4 demonstrated favorable safety and tolerability profiles in healthy subjects,maintaining a stable glucose-lowering effect for up to one week with a single administratio
BEIJING,Sept. 14,2024-- A report from People\'s Daily: The Yellow River,the "mother river" of the Chinese nation,nurtures the Chinese people and fosters Chinese civilization,together with th
BEIJING,Sept. 14,2024-- A report from People\'s Daily: Southeast of Tianshui city in northwest China\'s Gansu province,deep in the forests in the west of the Qinling Mountains,stands the peak of the M
ANAHEIM,Calif.,Sept. 14,2024-- At RE+ 2024,Sunwoda made a significant impact under the theme "Sunwoda Inside," underscoring its leadership in providing end-to-end energy storage solutions. W
MANILA,Philippines,Sept. 13,2024-- On September 12th,AI-driven recruitment platformBossjob proudly announced that it has surpassed 4 million registered users in the Philippines,thanks to a dual focus
The first publication of clinical data for YL201,featured in an oral presentation at ESMO 2024. Encouraging antitumor activity of YL201 in multiple solid tumor types,including SCLC,NPC,and wild-type
